Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia, Myeloid, Acute 45Breast Neoplasms 20Myelodysplastic Syndromes 19Prostatic Neoplasms 12Neoplasms 12Leukemia, Myelomonocytic, Chronic 12Carcinoma, Hepatocellular 10Stomach Neoplasms 9Recurrence 9Carcinoma, Non-Small-Cell Lung 8Neoplasm Metastasis 7Esophageal Neoplasms 7Uterine Cervical Neoplasms 6Sarcoma 6Ovarian Neoplasms 6Multiple Myeloma 6Lung Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Myeloproliferative Disorders 5Melanoma 5Lymphoma, Non-Hodgkin 5Lymphoma, B-Cell 5Esophageal Squamous Cell Carcinoma 5Colorectal Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Pancreatic Neoplasms 4Myelodysplastic-Myeloproliferative Diseases 4Leukemia, Biphenotypic, Acute 4Cholangiocarcinoma 4Thrombocythemia, Essential 3

Interventions

Fulvestrant 6olaparib 4Letrozole 4trastuzumab deruxtecan 3Aromatase Inhibitors 3Anastrozole 3sacituzumab govitecan 2pyrotinib 2eribulin 2dalpiciclib 2Paclitaxel 2Goserelin 2Gonadotropin-Releasing Hormone 2FCN-437c 2Capecitabine 2toripalimab 1talazoparib 1sonidegib 1ribociclib 1pembrolizumab 1neratinib 1liposomal doxorubicin 1elacestrant 1disitamab vedotin 1ceralasertib 1capivasertib 1balixafortide 1apatinib 1abemaciclib 1Vorinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Advanced Breast Cancer × Injections × Clear all
NCT07630103 2026-06-05

Efficacy and Safety of Trastuzumab Rezetecan or Trastuzumab Deruxtecan in Advanced Breast Cancer

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Not yet recruiting
100 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡